Nitrous Oxide Alters Functional Connectivity in Medial Limbic Structures in Treatment-Resistant Major Depression.
Charles R Conway, Ben Julian A Palanca, Thomas Zeffiro, Britt M Gott, Frank Brown, Victoria De Leon, Linda Barnes, Thomas Nguyen, Willa Xiong, Christina N Lessov-Schlaggar, Gemma Espejo, Steven Mennerick, Charles F Zorumski, Peter Nagele
medRxiv : the preprint server for health sciences August 17, 2024 preprint DOI: 10.1101/2024.08.12.24311729 via PubMed
Summary
AI-generated from the abstractNitrous oxide (N2O) reduces functional connectivity in mood-related brain networks in people with treatment-resistant major depression (TRD) but increases connectivity in healthy controls. In a crossover trial, 14 TRD patients and 16 healthy controls received one-hour inhalations of 50% N2O or placebo. Resting-state fMRI scans before, 2 hours, and 24 hours after inhalation showed that N2O progressively decreased connectivity in TRD patients across five brain networks (salience, default mode, reward, cingulo-opercular, and the dorsal nexus), while increasing connectivity in controls. The findings suggest N2O's antidepressant effects involve specific alterations in depressed brains.
Study at a glance
| Characteristics | Randomized crossover trial |
|---|---|
| Sample size | 30 |
| Population | Patients with treatment-resistant major depression (TRD) and non-depressed healthy controls |
| Dose | 50% N2O/oxygen |
| Duration | One-hour inhalation, with assessments at 2 hours and 24 hours post-inhalation |
| Registration | NCT02994433 |
| Key finding | Nitrous oxide reduces functional connectivity in mood-associated brain networks in treatment-resistant depression but increases connectivity in healthy controls. |
Abstract
While nitrous oxide (N2O) has demonstrated antidepressant properties in treatment-resistant major depression (TRD), little is known about neural mechanisms mediating these effects. Employing serial resting-state functional magnetic resonance imaging (rs-fMRI), we compared spatiotemporal effects of inhaled N2O on brain functional connectivity in TRD patients (n=14) and non-depressed healthy controls (n=16, CNTL). Participants received sequential, one-hour inhalations of either 50% N2O/oxygen or air/oxygen (placebo), with sessions separated by at least one month in random cross-over order. BOLD-contrast rs-fMRI scans were acquired at three time points: pre-inhalation, 2 hours post-inhalation, and 24 hours post-inhalation. For the rs-fMRI functional connectivity analyses, five a priori seeds in medial limbic structures targeted cortical networks implicated in major depression - the salience, anterior and posterior default mode, reward, and cingulo-opercular networks - and a nexus in the dorsal paracingulate region previously identified in MDD ("dorsal nexus"). Depression, dissociation, and psychosis assessments were made before and after inhalations. In TRD patients, functional connectivity was reduced in all seeded networks and the voxel-wise global analysis after N2O exposure. N2O progressively decreased connectivity in patients with TRD but increased connectivity in healthy controls. In TRD patients, each seeded network demonstrated post-inhalation functional connectivity reductions in the dorsal paracingulate gyrus ("dorsal nexus"). This study further elucidates neural mechanisms underlying the antidepressant properties of N2O, supporting the notion that N2O specifically alters mood-associated brain regions in the depressed brain state by reducing functional connectivity within these brain networks. The trial was registered at ClinicalTrials.gov (NCT02994433).